Kathi Niffenegger - Chief Financial Officer at Edesa Biotech, Inc.

Issuer-level insider activity

Role
Chief Financial Officer
Issuer ticker
EDSA on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Kathi Niffenegger since 25 Aug 2025

Reported holdings for Kathi Niffenegger in Edesa Biotech, Inc.

Form 4 holding Chief Financial Officer

Edesa Biotech, Inc.

Security class
Common Shares
Shares / value
10,715
Estimated value
$28,230
Report date
02 Nov 2022
Price
$2.63
Ownership
By Trust
Form 4 holding Chief Financial Officer

Edesa Biotech, Inc.

Security class
Common Share Warrants (Right to Buy)
Shares / value
4,444
Estimated value
Report date
02 Nov 2022
Price
Ownership
By Trust
Underlying class
Common Shares
Underlying amount

Transaction history for Kathi Niffenegger in Edesa Biotech, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .